p53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA

Cancer Research

Volumn 63, Issue 13, 2003, Pages 3729-3734

  Yoshida, Yoichiro ^a   Izumi, Hiroto ^a   Torigoe, Takayuki ^a   Ishiguchi, Hiroshi ^a   Itoh, Hideaki ^a   Kang, Dongchon ^b   Kohno, Kimitoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CISPLATIN; GLUTATHIONE TRANSFERASE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL FRACTIONATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA DAMAGE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOPRECIPITATION; MITOCHONDRION; OXIDATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

BASE SEQUENCE; BINDING SITES; CLONING, MOLECULAR; DNA DAMAGE; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, MITOCHONDRIAL; DNA, NEOPLASM; DNA-BINDING PROTEINS; HUMANS; KB CELLS; KINETICS; MITOCHONDRIAL PROTEINS; NUCLEAR PROTEINS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038418297     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Parisi, M. A., and Clayton, D. A. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science (Wash, DC). 252: 965-969, 1991.
2. Pil, P. M., and Lippard, S. J. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science (Wash. DC), 256: 234-237, 1992.
3. Hughes, E. N., Engelsberg, B. N., and Billings, P. C. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J. Biol. Chem., 267: 13520-13527, 1992.
4. Bilings, P. C., Davis, R. J., Engelsberg, B. N., Skov, K. A., and Hughes, E. N. Characterization of high mobility group protein binding to cisplatin-damaged DNA. Biochem. Biophys. Res. Commun., 188: 1286-1294, 1992.
5. Turchi, J. J., Li, M. and Henkels, K. M. Cisplatin-DNA binding specificity of calf high mobility group 1 protein. Biochemistry, 35: 2992-3000, 1996.
6. Yoshida, Y., Izumi, H., Ise, T., Uramoto, H., Torigoe, T., Ishiguchi, H., Murakami, T., Tanabe, M., Nakayama, Y., Itoh, H., Kasai, H. and Kohno, K. Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA. Biochem. Biophys. Res. Commun., 295: 945-951, 2002.
7. Larsson, N. G., Wang, J., Wilhemsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S., and Clayton, D. A. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet., 18: 231-236, 1998.
8. Wang, J., Silva, J. P., Gustafsson, C. M., Rustin, P., and Larsson, N. G. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc. Natl. Acad. Sci. USA, 98: 4038-4043, 2001.
9. Katsumoto, T., Higaki, K., Ohno, K., and Onodera, K. Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol. Cell. 84: 167-173, 1995.
10. Merrick, B. A., He, C., Witcher, L. L., Patterson, R. M., Reid, J. J., Pence-Pawlowski, P. M., and Selkirk, J. K. HSP binding and mitochondrial localization of p53 protein in human HT1080 and mouse C3H10T1/2 cell lines. Biochim. Biophys. Acta. 1297: 57-68, 1996.
11. Marchenko, N. D., Zaika, A., and Moll, U. M. Death signal-induced localization of p53 protein to mitochondria. J. Biol. Chem., 275: 16202-16212, 2000.
12. Sansome, C., Zaika, A., Marchenko, N. D., and Moll. U. M. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett., 488:110-115, 2001.
13. Donahue, R. J., Razmara, M., Hoek, J. B., and Knudsen, T. B. Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function. FASEB J., 15: 635-644, 2001.
14. Chang, N. S. A potential role of p53 and WOX1 in mitochondrial apoptosis. Int. J. Mol. Med., 9: 19-24, 2002.
15. Caelles, C., Helmberg, A., and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond,). 370: 220-223, 1994.
16. Wagner, A. J., Kokontis, J. M., and Hay, N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev., 8: 2817-2830, 1994.
17. Polyak, K., Xia, Y., Zweler, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis. Nature (Lond.). 389: 300-305, 1997.
18. Johnson, T. M., Yu, Z.-X., Ferrans, V. J., Lownstein, R. A., and Finkel, T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 93: 11848-11852, 1996.
19. Bakalkin, G., Yakovleva, T., Selivanova, G., Magunusson, K. P., Szekely, L., Kiseleva, E., Klein, G., Terenius, L., and Wiman, K. G. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA, 91: 413-417, 1994.
20. Lee, S., Elenbaas, B., Levine, A., and Griffith, J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81: 323-331, 1995.
21. Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J. M., Wang, Z., Freidberg, E. C., Evans, M. K., and Taffe, B. G. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet., 10: 188-195, 1995.
22. Imamura, T., Izumi, H., Nagatani, G., Ise, T., Nomoto, M., Iwamoto, Y., and Kohno, K. Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J. Biol. Chem., 276: 7534-7540, 2001.
23. Okamoto, T., Izumi, H., Imamura, T., Takano, H., Ise, T., Uchiumi, T., Kuwano, M., and Kohno, K. Direct interaction of p53 with the Y-box binding protein. YB-1: a mechanism for regulation of human gene expression. Oncogene, 19: 6194-6202, 2000.
24. +-ATPase c subunit gene (ATP6L) in response to anticancer agents. J. Biol. Chem., 277: 36534-36543, 2002.
25. Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Disruption of p53 in human cancer cells alters the response to therapeutic agents. J. Clin. Investig., 104: 263-269, 1999.
26. Ohno, T., Umeda, S., Hamasaki, N., and Kang, D. Binding human mitochondrial transcription factor A. an HMG box protein, to a four-way DNA junction. Biochem. Biophys. Res. Commun., 271: 492-498, 2000.
27. Bustin, M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol., 19: 5237-5246, 1999.
28. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Wash. DC). 281: 1309-1312, 1998.
29. Hengartner, M. O. The biochemistry of apoptosis. Nature (Lond.), 407: 770-776, 2000.
30. Kroemer, G., and Reed, J. C. Mitochondrial control of cell death. Nat. Med., 6: 513-519, 2000.
31. Ibrahim, M. M., Razmara, M., Nguyen, D., Donahue, R. J., Wubah, J. A., and Knudsen, T. B. Altered expression of mitochondrial 16S ribosomal RNA in p53-deficient mouse embryos revealed by differential display. Biochim. Biophys. Acta. 1403: 254-264, 1998.
32. Okamura, S., Ng, C. C., Koyama, K., Arakawa, H., Monden, M., and Nakamura, Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol. Res., 11: 281-285, 1999.
33. Kato, M. V. The mechanisms of death of an erythroleukemic cell line by p53: involvement of the microtubule and mitochondria. Leuk. Lymphoma., 33: 181-186, 1999.
34. Levine, A. J. p53. the cellular gatekeeper for growth and division. Cell. 88: 323-331, 1997.
35. Harris, C. C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst., 88: 1442-1455, 1996.
36. Gottlieb, T. M., and Oren, M. p53 and apoptosis. Semin. Cancer Biol., 8: 359-368, 1998.
37. Jamieson, E. R., and Lippard, S. J. Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev., 99: 2467-2498, 1999.
38. Lipscomb, L. A., Peek, M. A., Morningstar, M. L., Verghis, S. M., Miller, E. M., Rich, A., Essigmann, J. M., and Williams, L. D. X-ray structure of a DNA decamer containing 7,8-dihydro-8-oxoguanine. Proc. Natl. Acad. Sci. USA, 92: 719-723, 1995.
39. Sigal, A., Matas, D., Almog, N., Goldfinger, N., and Rotter, V. The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis. Oncogene, 20: 4891-4898, 2001.